{
    "case_number": "CAC-UDRP-104801",
    "time_of_filling": "2022-08-22 09:23:29",
    "domain_names": [
        "buymicardis.top"
    ],
    "case_administrator": "Denisa Bilík (CAC) (Case admin)",
    "complainant": [
        "BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG"
    ],
    "complainant_representative": "NAMESHIELD S.A.S.",
    "respondent": [
        "Fidel M Finley"
    ],
    "respondent_representative": null,
    "factual_background": "Facts asserted by the Complainant and not contested by the Respondent:\r\n\r\nThe Complainant is a German global research-driven pharmaceutical enterprise founded in 1885 with approximately 50,000 employees. The three business areas of BOEHRINGER are human pharmaceuticals, animal health and biopharmaceuticals. In 2017 alone, net sales of the BOEHRINGER group of companies amounted to about EUR 18.1 million.\r\n\r\nThe product which is sold under the MICARDIS trademark is a medicine prescribed for the treatment of hypertension.\r\n\r\nThe disputed domain name <buymicardis.top> was registered on July 20, 2022 and resolves to a registrar parking page.",
    "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": "No administratively compliant Response has been filed.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Alfred Meijboom"
    ],
    "date_of_panel_decision": "2022-09-21 00:00:00",
    "informal_english_translation": "The Complainant owns several trademarks for cardio-vascular preparations, including international trademark MICARDIS with registration number 523578 of May 18, 1988 and international trademark MICARDIS with registration number 691750 of March 13, 1998, for different European jurisdictions, and Botswana, Georgia and China, respectively.",
    "decision_domains": {
        "BUYMICARDIS.TOP": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}